How Prior Authorization Works for CVS Caremark Wegovy Coverage
Prior authorization is a review that happens before a plan agrees to pay. The prescriber submits clinical information, a reviewer working for the pharmacy benefit manager measures it against criteria the plan sponsor selected, and an approval is issued for a fixed period and a named dose. Nothing about the process decides whether the medication is appropriate, only whether the benefit pays.
Two organizations, two different jobs
Understanding who does what removes most of the confusion. CVS Caremark is a pharmacy benefit manager. It maintains formulary templates, employs the reviewers, and operates the electronic systems that receive requests. The plan sponsor, normally an employer or a health plan, chooses which template to buy, whether the weight-management category is included, and which optional rules to switch on.
The practical consequence is that criteria for the same drug differ from one employer to the next even though the same organization reviews both files. A criteria document circulating online may be a standard template that no longer matches the version attached to a particular member’s card. The authoritative copy is the one the plan supplies on request, and members are entitled to ask for it.
Where a request starts
A prescriber initiates the request, not the patient. Most requests now travel through electronic prior authorization built into the prescribing software, which pulls a question set for the specific drug and plan and returns a determination faster than fax or telephone. Where the electronic path is unavailable, a plan-specific form is completed and submitted directly.
Patients have one job at this stage and it matters: making sure the office has everything it needs. Weight and height records, dated notes on previous attempts and previous medications, and documentation of any weight-related condition all sit in the chart or they do not. A practice cannot submit what nobody wrote down.
What a reviewer is actually reading
Criteria vary, but the categories reviewers work through are consistent across the industry. The request is checked against the approved indication in the labeling, against whatever weight or measurement threshold the plan adopted, against documentation of any required accompanying condition, and against evidence of prior therapy where a step requirement is switched on. Some sponsors add a requirement to document participation in a structured lifestyle program alongside the prescription.
Step therapy deserves separate mention because it is inconsistent by nature. Health policy research examining step protocols across plans found substantial variation both in how often they are applied and in what they require, including within a single organization’s book of business. A step denial says a preferred product has not yet been tried or documented as failed. It is not a judgment about the requested drug.
Timing, and what “pending” means
Standard requests are usually decided within a few business days once complete information arrives, and expedited review exists for situations where waiting would cause harm. The clock that matters starts when the plan has a complete submission, not when the prescriber first opened the form, which is why an incomplete file can sit for two weeks without anyone violating a deadline.
| Stage | Who acts | What comes out of it |
|---|---|---|
| Claim rejects at the pharmacy | Pharmacy system | A message naming the reason |
| Request prepared | Prescriber’s office | Clinical file plus plan question set |
| Clinical review | Benefit manager reviewer | Approval, denial, or request for more information |
| Approval issued | Benefit manager | Named dose and quantity, fixed end date |
| Reauthorization | Prescriber’s office | Continuation, usually with response data |
| Denial | Member and prescriber | Written reason and appeal instructions |
An approval is temporary
Authorizations carry end dates, commonly six or twelve months, and continuation is a fresh review rather than an automatic renewal. Reauthorization criteria usually ask for evidence of response and continued adherence. The most avoidable gap in this whole system is an expiry nobody diarized, discovered at the pharmacy counter on a refill day.
Renewals and appeals do not always succeed, and when a plan simply will not pay, the practical question becomes what the drug costs on its own. Several telehealth providers, among them Ro, Hims and Hers, and HealthRX, now post cash pricing for Wegovy that a household can set beside the manufacturer’s own self-pay quote before deciding how much more effort a coverage fight is worth.
When the answer is no
A denial arrives with a stated reason and instructions for challenging it, and the correct next move depends entirely on that reason. A documentation gap is fixed by supplying the missing element and resubmitting. A step requirement is answered with dated evidence of the prior trial. A category exclusion is not a review outcome at all and cannot be appealed on clinical grounds, because no clinical rule was applied in the first place.
Where the exception route also closes, pricing a cash program becomes the practical next step, and the posted monthly figure matters less than the provider behind it, since supervision, dose adjustment, and laboratory follow-up are what separate one program from another. Compounded semaglutide, which several such programs supply, is not an FDA-approved product, and FDA has been explicit that compounded medicines are not reviewed for safety, effectiveness, or quality before reaching patients.
Questions people ask
Can a patient file the request instead of the prescriber?
Generally no. The submission requires clinical documentation that only the practice holds, and plans route these through prescriber channels. Patients can chase progress, confirm the plan received a complete file, and request a copy of the criteria being applied, all of which speeds things up more than calling for status alone.
How long does an approval last?
Usually six or twelve months, stated on the approval notice. Continuation requires a new review that often asks for documented response to treatment. Diarizing the end date sixty days ahead gives the office time to file the renewal before a refill rejects, which is the failure people hit most often.
Does an approval fix the price?
No. Approval settles whether the plan pays; the amount owed still depends on tier placement, deductible status, and any coinsurance percentage. Someone can hold a valid authorization and still face a large bill in January because the deductible reset on the first day of the plan year.
Is prior authorization applied to every weight-management drug?
Almost always, where the category is covered at all. Utilization management is the standard tool for high-cost classes, and research on demand response to these controls shows they measurably change what gets dispensed. Plans that cover the category without any review of this kind are the exception rather than the norm.